Cart (0 Items)
Your cart is currently empty.
View Productssize | 100ug, 50ug |
---|---|
Brand | ProteoGenix |
Product type | Recombinant Proteins |
Host Species | Escherichia coli (E. coli) |
Applications | Elisa, WB |
Product name | Human Galectin-1 (GAL1) recombinant protein |
---|---|
Uniprot ID | P09382 |
Uniprot link | http://www.uniprot.org/uniprot/P09382 |
Origin species | Homo sapiens (Human) |
Expression system | Prokaryotic expression |
Sequence | MACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFDLEHHHHHH |
Molecular weight | 15.61kDa |
Protein delivered with Tag? | Yes |
Purity estimated | 80% |
Buffer | 50 mM Tris-HCl pH 8, 150 mM NaCl |
Form | Lyophilized |
Delivery condition | Dry Ice |
Delivery lead time in business days | 5-7 |
Storage condition | 4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection) |
Brand | ProteoGenix |
Host species | Escherichia coli (E.coli) |
Fragment Type | Full-length |
Aliases /Synonyms | LGALS1, GBP, HLBP14, Galaptin, Lectin,Galactoside-Binding Soluble 1, 14 kDa laminin-binding protein, Lactose-binding lectin 1, Putative MAPK-activating protein PM12, S-Lac lectin |
Reference | PX-P4049 |
Note | For research use only |
Galectin-1 (Gal-1, GAL1) is a member of galectin Galectin is a type of animal lectin. Affinity and significant sequence similarity in carbohydrates. in the place. It is a homodimer with a molecular weight subunit of 14.5 kDa and each subunit contains six cysteine residues. Cysteine residues must be in the free state to maintain a molecular structure that can show readability. This endogenous lectin is widely expressed at the sites of inflammation and tumor growth and is considered an attractive immunosuppressant, which can restore tolerance and homeostasis of immune cells in autoimmune and inflammatory environments. On the other hand, galectin-1 contributes to different steps in tumor progression, including tumor cell adhesion, migration, and immune activation, indicating that galectin-1 blockade may generate benefits in the treatment of cancer. Cancer. Several potential glycoprotein ligands of galectin-1 have been identified, including lysosomal membrane glycoprotein and fibronectin, laminin, and CD43 and CD45 T-cell glycoprotein. Evidence shows that Gal-1 and its ligands are one of the main regulators of the immune response, such as T cell homeostasis and survival, T cell immune diseases, inflammation and allergies, and host interactions. -pathogen.
Related products
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.